Executive Branch

RSS Feed for this category

Feds' New Cell Phone Spying Device Raising Privacy Concerns [FEATURE]

special to Drug War Chronicle by independent investigative journalist Clarence Walker, freelancewriter82@gmail.com

Blocked by a Supreme Court decision from using GPS tracking devices without a warrant, federal investigators and other law enforcement agencies are turning to a new, more powerful and more threatening technology in their bid to spy more freely on those they suspect of drug crimes. That's leading civil libertarians, electronic privacy advocates, and even some federal judges to raise the alarm about a new surveillance technology whose use has yet to be taken up definitively by the federal courts.

StingRay cell phone spying device (US Patent photo)
The new surveillance technology is the StingRay (also marketed as Triggerfish, IMSI Catcher, Cell-site Simulator or Digital Analyzer), a sophisticated, portable spy device able to track cell phone signals inside vehicles, homes and insulated buildings. StingRay trackers act as fake cell towers, allowing police investigators to pinpoint location of a targeted wireless mobile by sucking up phone data such as text messages, emails and cell-site information.

When a suspect makes a phone call, the StingRay tricks the cell into sending its signal back to the police, thus preventing the signal from traveling back to the suspect's wireless carrier. But not only does StingRay track the targeted cell phone, it also extracts data off potentially thousands of other cell phone users in the area.

Although manufactured by a Germany and Britain-based firm, the StingRay devices are sold in the US by the Harris Corporation, an international telecommunications equipment company. It gets between $60,000 and $175,000 for each Stingray it sells to US law enforcement agencies.

[While the US courts are only beginning to grapple with StingRay, the high tech cat-and-mouse game between cops and criminals continues afoot. Foreign hackers reportedly sell an underground IMSI tracker to counter the Stingray to anyone who asks for $1000. And in December 2011, noted German security expert Karsten Nohl released "Catcher Catcher," powerful software that monitors a network's traffic to seek out the StingRay in use.]

Originally intended for terrorism investigations, the feds and local law enforcement agencies are now using the James Bond-type surveillance to track cell phones in drug war cases across the nation without a warrant. Federal officials say that is fine -- responding to a Freedom of Information Act (FOIA) request filed by the Electronic Freedom Foundation (EFF) and the First Amendment Coalition, the Justice Department argued that no warrant was needed to use StingRay technology.

"If a device is not capturing the contents of a particular dialogue call, the device does not require a warrant, but only a court order under the Pen Register Statute showing the material obtained is relevant to an ongoing investigation," the department wrote.

The FBI claims that it is adhering to lawful standards in using StingRay. "The bureau advises field officers to work closely with the US Attorney's Office in their districts to comply with legal requirements," FBI spokesman Chris Allen told the Washington Post last week, but the agency has refused to fully disclose whether or not its agents obtain probable cause warrants to track phones using the controversial device.

And the federal government's response to the EFF's FOIA about Stingray wasn't exactly responsive. While the FOIA request generated over 20,000 records related to StingRay, the Justice Department released only a pair of court orders and a handful of heavily redacted documents that didn't explain when and how the technology was used.

The LA Weekly reported in January that the StingRay "intended to fight terrorism was used in far more routine Los Angeles Police criminal investigations," apparently without the courts' knowledge that it probes the lives of non-suspects living in the same neighborhood with a suspect.

Critics say the technology wrongfully invades technology and that its uncontrolled use by law enforcement raised constitutional questions. "It is the biggest threat to cell phone privacy you don't know about," EFF said in a statement.

ACLU privacy researcher Christopher Soghoian told a Yale Law School Location Tracking and Biometrics Conference panel last month that "the government uses the device either when a target is routinely and quickly changing phones to thwart a wiretap or when police don't have sufficient cause for a warrant."

"The government is hiding information about new surveillance technology not only from the public, but even from the courts," ACLU staff attorney Linda Lye wrote in a legal brief in the first pending federal StingRay case (see below). "By keeping courts in the dark about new technologies, the government is essentially seeking to write its own search warrants, and that's not how the Constitution works."

Lye further expressed concern over the StingRay's ability to interfere with cell phone signals in violation of Federal Communication Act. "We haven't seen documents suggesting the LAPD or any other agency have sought or obtained FCC authorization," she wrote.

StingRay pricing chart (publicintelligence.net)
"If the government shows up in your neighborhood, essentially every phone is going to check in with the government," said the ACLU's Soghoian. "The government is sending signals through people's walls and clothes and capturing information about innocent people. That's not much different than using invasive technology to search every house on a block," Soghoian said during interviews with reporters covering the StingRay story.

Advocates also raised alarms over another troubling issue: Using the StingRay allows investigators to bypass the routine process of obtaining fee-based location data from cell service providers like Sprint, AT&T, Verizon, T-Mobile and Comcast. Unlike buying location data fro service providers, using StingRay leaves no paper trail for defense attorneys.

Crack defense attorney Stephen Leckar who scored a victory in a landmark Supreme Court decision over the feds' warrantless use of a GPS tracker in US v. Jones, a cocaine trafficking case where the government tracked Jones' vehicle for weeks without a warrant, also has concerns.

"Anytime the government refuses to disclose the ambit of its investigatory device, one has to wonder, what's really happening," he told the Chronicle. "If without a warrant the feds use this sophisticated device for entry into people's homes, accessing private information, they may run afoul of a concurring opinion by Justice Alito, who ruled in US v Jones whether people would view unwarranted monitoring of their home or property as Constitutionally repugnant."

Leckar cited Supreme Court precedent in Katz v. US (privacy) and US v. Kyllo (thermal imaging), where the Supreme Court prohibited searches conducted by police from outside the home to obtain information behind closed doors. Similar legal thinking marked February's Supreme Court decision in a case where it prohibited the warrantless use of drug dogs to sniff a residence, Florida v. Jardines.

The EFF FOIA lawsuit shed light on how the US government sold StingRay devices to state and local law enforcement agencies for use specifically in drug cases. The Los Angeles and Fort Worth police departments have publicly acknowledged buying the devices, and records show that they are using them for drug investigations.

"Out of 155 cell phone investigations conducted by LAPD between June and September 2012, none of these cases involved terrorism, but primarily involved drugs and other felonies," said Peter Scheer, director of the First Amendment Center.

The StingRay technology is so new and so powerful that it not only raises Fourth Amendment concerns, it also raises questions about whether police and federal agents are withholding information about it from judges to win approval to monitor suspects without meeting the probable cause standard required by the Fourth. At least one federal judge thinks they are. Magistrate Judge Brian Owsley of the Southern District of Texas in Corpus Christi told the Yale conference federal prosecutors are using clever techniques to fool judges into allowing use of StingRay. They will draft surveillance requests to appear as Pen Register applications, which don't need to meet the probable cause standards.

"After receiving a second StingRay request," Owsley told the panel, "I emailed every magistrate judge in the country telling them about the device. And hardly anyone understood them."

In a earlier decision related to a Cell-site Simulator, Judge Owsley denied a DEA request to obtain data information to identify where the cell phone belonging to a drug trafficker was located. DEA wanted to use the suspect's E911 emergency tracking system that is operated by the wireless carrier. E911 trackers reads signals sent to satellites from a cell phone's GPS chip or by triangulation of radio transmitted signal. Owsley told the panel that federal agents and US attorneys often apply for a court order to show that any information obtained with a StingRay falls under the Stored Communication Act and the Pen Register statute.

DEA later petitioned Judge Owsley to issue an order allowing the agent to track a known drug dealer with the StingRay. DEA emphasized to Owsley how urgently they needed approval because the dealer had repeatedly changed cell phones while they spied on him. Owsley flatly denied the request, indicating the StingRay was not covered under federal statute and that DEA and prosecutors had failed to disclose what they expected to obtain through the use of the stored data inside the drug dealer's phone, protected by the Fourth Amendment.

"There was no affidavit attached to demonstrate probable cause as required by law under rule 41 of federal criminal procedures," Owsley pointed out. The swiping of data off wireless phones is "cell tower dumps on steroids," Owsley concluded.

But judges in other districts have ruled favorably for the government. A federal magistrate judge in Houston approved DEA request for cell tower data without probable cause. More recently, New York Southern District Federal Magistrate Judge Gabriel Gorenstein approved warrantless cell-site data.

"The government did not install the tracking device -- and the cell user chose to carry the phone that permitted transmission of its information to a carrier," Gorenstein held in that opinion. "Therefore no warrant is needed."

In a related case, US District Court Judge Liam O'Grady of the Northern District of Virginia ruled that the government could obtain data from Twitter accounts of three Wikileakers without a warrant. Because they had turned over their IP addresses when they opened their Twitter accounts, they had no expectation of privacy, he ruled.

"Petitioners knew or should have known that their IP information was subject to examination by Twitter, so they had a lessened expectation of privacy in that information, particularly in light of their apparent consent to the Twitter terms of service and privacy policy," Judge O'Grady wrote.

A federal judge in Arizona is now set to render a decision in the nation's first StingRay case. After a hearing last week, the court in US v. Rigmaiden is expected to issue a ruling that could set privacy limits on how law enforcement uses the new technology. Just as the issue of GPS tracking technology eventually ended up before the Supreme Court, this latest iteration of the ongoing balancing act between enabling law enforcement to do its job and protecting the privacy and Fourth Amendment rights of citizens could well be headed there, too.

DEA Targets FedEx, UPS in Online Pharmacy Battle

Charged with cracking down on the diversion of prescription drugs, the DEA has pursed doctors, pharmacists, pharmacy chains, and wholesale drug suppliers. It has now turned a baleful eye on shipping companies as well, with differing results -- at least so far.

The Orlando Sentinel reported Tuesday that both UPS and FedEx had admitted in corporate filings that they were the targets of DEA probes into packages of pills shipped from online pharmacies. Prescriptions filled by online pharmacies are illegal if there is not a real doctor-patient relationship, and the DEA maintains that prescriptions written by "cyber doctors" relying on online questionnaires are not legal.

FedEx has strongly pushed back against the DEA probe, but UPS has now buckled under the pressure. In a Friday statement, the DEA announced that UPS had agreed to forfeit $40 million it had been paid for shipments by online pharmacies and to enter into a "compliance program" to ensure online pharmacies can't use its services. The deal was part of a non-prosecution agreement the shipper signed with federal prosecutors in Northern California.

DEA accused UPS of knowingly shipping the illegally-prescribed drugs between 2003 and 2010 because "it was on notice, through some employees" that such activities were occurring. DEA also accused UPS of failing to do anything about it.

"DEA is aggressively targeting the diversion of controlled substances, as well as those who facilitate their unlawful distribution," said DEA Administrator Michele Leonhart. "This investigation is significant and DEA applauds UPS for working to strengthen and enhance its practices in order to prevent future drug diversion."

FedEx may prove a tougher nut to crack. Officials there called the federal probe "absurd and disturbing" and said it threatened customer privacy. They also accused the DEA of failing to cooperate with them in efforts to resolve the problem.

"We are a transportation company -- we are not law enforcement, we are not doctors and we are not pharmacists," FedEx spokesman Patrick Fitzgerald said in a prepared statement. "We have no interest in violating the privacy of our customers by opening and inspecting their packages in an attempt to determine the legality of the contents. We stand ready and willing to support and assist law enforcement. We cannot, however, do their jobs for them."

FedEx complained that rather than working with the shipping industry to come up with solutions, the Justice Department appeared focused on finding ways to prosecute shippers.

"This is unwarranted by law and a dangerous distraction at a time when the purported illegal activity by these pharmacies continues," Fitzgerald said.

FedEx has been a major campaign contributor to US Rep. John Mica (R-FL), whom the Sentinel reported had sent a letter to Leonhart and Attorney General Eric Holder asking them to recognize "the difficulty and unfairness of requiring those carriers to assume responsibility for the legality and validity of the contents of the millions of sealed packages that they pick up and deliver ever day."

Mica told the Sentinel that while he is "concerned about prescription drugs," it was inefficient to try to turn shipping companies into drug policy enforcers. "You can't stop commerce; you can't open every package," Mica said. "I'm only asking them for a reasonable approach."

But it doesn't appear that DEA and the Justice Department see things the same way as Rep. Mica does.

San Francisco, CA
United States

Medical Marijuana Update

Legislatures are in session across the land, and that's reflected in our update this week. Bills are moving, generally, though not always in the right direction. Meanwhile, Arkansas looks ahead to 2014, and Oakland wants back in the Harborside case. Let's get to it:

Arkansas

Last Monday, activists submitted a medical marijuana ballot initiative to the state attorney general's office. Arkansans for Medical Cannabis plans to try again in 2014 after their 2012 initiative surprised just about everybody by coming up just short with 49% of the vote.

California

Last Wednesday, the city of Oakland filed notice that it will appeal a federal magistrate's decision to dismiss its lawsuit in support of Harborside Health Center in its ongoing battle with the federal government. Oakland sued after federal prosecutors moved to seize the property where Harborside is located.

Also last Wednesday, Butte County prosecutors dropped charges against a dispensary operator in the wake of Fourth District Court of Appeal's reversal of the conviction of San Diego dispensary operator Jovan Jackson. That decision held that members of a collective do not need to actually work growing plants. Prosecutors said they were dropping a case against dispensary operator Rick Tognoli because the Jackson ruling "has made it almost impossible to prosecute dispensaries that are disguised as collectives and making supposedly no profit."

Hawaii

On Tuesday, the House passed two medical marijuana bills. House Bills 667 and 668 are designed to improve the state's existing medical marijuana program. They now go before the state Senate.

Iowa

On Monday, a medical marijuana bill was pronounced dead even though it was approved by a Senate subcommittee. The chairman of the subcommittee, Sen. Joe Bolkom (D-Iowa City), said the bill is unlikely to advance because it lacks support in the full committee. A similar bill was rejected by a House subcommittee earlier this session.

Illinois

On Wednesday, a medical marijuana bill won a House committee vote. The bill, House Bill 1, passed the House Health and Human Services Committee on an 11-4 vote and now goes before the full House. Qualified patients would be able to obtain marijuana from one of up to 60 dispensaries, which would acquire marijuana from up to 22 cultivation centers. The Illinois Department of Agriculture, Department of Health, and Department of Financial & Professional Regulation would regulate the cultivation, acquisition, and distribution of marijuana.

Montana

Last Thursday, two minor players in a dispensary were sentenced to time served by a federal judge. Doran Leslie Hewitt had kept patient records and Travis Birdinground had delivered medical marijuana to patients. They had worked for Eastern Montana Cannabis. The judge in the case has sentenced all five Eastern Montana Cannabis defendants to terms shorter than the federal guideline ranges.

New Jersey

On Monday, a Senate committee approved a bill to protect medical marijuana patients on organ transplant lists. The bill would ensure that a person's use of medical marijuana would not prohibit him from receiving needed medical care, including organ transplants. It was approved by the Senate Health, Human Services and Senior Citizens Committee. The bill, S-1220, would provide that a registered, qualifying patient's authorized use of medical marijuana would be considered equivalent to using other prescribed medication rather than an illicit substance and therefore would not disqualify the person from needed medical care, such as an organ transplant. It now heads to floor vote in the Senate.

Oregon

Last Thursday, a bill that would add PTSD to the list of qualifying debilitating medical conditions passed the Senate Health and Healthcare Committee. It now goes before the Senate Judiciary Committee. Senate Bill 281 passed out of committee on a 4-1 vote.

US, International Drug Warriors Attack State Marijuana Legalization [FEATURE]

As the nation awaits the Obama administration's response to marijuana legalization votes in Colorado and Washington, Tuesday saw a two-pronged attack on the whole notion. On the one hand, former drug czars and Drug Enforcement Administration (DEA) heads lined up to urge the administration to act now to strangle legalization in its crib, while on the other, the International Narcotics Control Board (INCB) warned that allowing states to legalize would violate international drug control treaties.

"S.O.S." web site celebrates defeat of Hawaii marijuana legalization bill
Legalization supporters rejected the attacks, comparing the ex-DEA chiefs to Prohibition agents seeking to justify their efforts and dismissing the global anti-drug bureaucrats as largely irrelevant.

In a joint letter under the auspices of the anti-drug reform group Save Our Society From Drugs, eight former heads of the DEA and four former heads of the Office of National Drug Control Policy urged the federal government to act now to nullify the votes in Colorado and Washington. The same group similarly called on Attorney General Holder to speak out against those state initiatives last September, but he failed to do so.

Holder, who said last week his decision will be "coming soon," was scheduled to appear before the Senate Judiciary Committee Wednesday. The retired drug fighters urged senators to press him on the issue.

Holder's actual appearance, though, was anticlimactic. He told the committee only that he hoped, again, to be able to announce a policy "relatively soon."

That prompted committee chair Sen. Patrick Leahy (D-VT) to hand out some advice of his own. "If you're going to be -- because of budget cuts -- prioritizing matters, I would suggest there are more serious things than minor possession of marijuana, but it's a personal view," Leahy told Holder, adding that more states were sure to follow in Colorado's and Montana's footsteps.

That's not what the drug warriors were telling Holder.

"We, the undersigned, strongly support the continued enforcement of federal law prohibiting the cultivation, distribution, sale, possession, and use of marijuana -- a dangerous and addictive drug which already has severe harmful effects on American society," they wrote. "We also respectfully request your committee at its March 6 hearing to encourage Attorney General Eric Holder to adhere to long-standing federal law and policy in this regard, and to vigorously enforce the Controlled Substances Act (CSA)."

The signatories suggested that senators ask Holder is he still believed in the Supremacy Clause when it comes to conflicts between state and federal law and why he isn't enforcing the Controlled Substances Act in Colorado and Washington. They also suggested asking him "what is being done about our international drug treaty obligations," noting that they require the federal government to enforce marijuana prohibition.

And speaking of international drug treaty obligations, the INCB, which is charged with ensuring that countries live up to them, also criticized marijuana legalization as it issued its 2012 Annual Report.

Noting the popular votes in favor of legalization in Colorado and Washington, INCB reiterated that "the legalization of cannabis for non-medical and non-scientific purposes would be in contravention to the provisions of the 1961 Convention as amended by the 1972 Protocol."

The INCB also took a shot at medical marijuana, noting that "the control requirements that have been adopted in the 17 states in question and in the District of Columbia under the 'medical' cannabis schemes fall short of the requirements set forth in articles 23 and 28 of the 1961 Convention as amended by the 1972 Protocol."

And, also expressing concerns about decriminalization moves, INCB "requests that the government of the United States take effective measures to ensure the implementation of all control measures for cannabis plants and cannabis, as required under the 1961 Convention, in all states and territories falling within its legislative authority."

The two-pronged attack excited a quick response from drug reform groups and at least one Democratic congressman.

"As Supreme Court Justice Louis Brandeis once observed, states are the laboratories of democracy. The federal government should concentrate on shutting down meth labs -- not the laboratories of democracy. The people of Colorado and Washington voted to implement these laws, and the federal government should respect their will. States have a right to determine their own possession laws," said Rep. Steven Cohen (D-TN) in a Tuesday statement.

"If the people of Colorado and Washington want to legalize small amounts of marijuana, that is their decision. It is arrogant of these former DEA chiefs to encourage the President to nullify these laws," Cohen continued. "The fact that these former DEA chiefs are so focused on marijuana possession is why we have lost the war on drugs. The war should be on heroin, meth, crack, cocaine and unauthorized use of prescription drugs -- not marijuana possession."

[Ed: We don't think war on those other drugs is a good thing either -- to the extent at least that "war" means arresting and incarcerating people. Not that we want underground meth labs all over the place. But meth is going to be supplied by someone in some way, despite enforcement efforts, so long as there are people who want to use it. We're losing the "war on drugs" because it is prohibition based, and prohibition doesn't work. The government's focus on marijuana enforcement only highlights the sheer senseless of it all. -DB]

"The former DEA chiefs' statement can best be seen as a self-interested plea to validate the costly and failed policies they championed but that Americans are now rejecting at the ballot box," said Ethan Nadelmann, executive director of the Drug Policy Alliance. "They obviously find it hard to admit that -- at least with respect to marijuana -- their legacy will be much the same as a previous generation of agents who once worked for the federal Bureau of Prohibition enforcing the nation’s alcohol prohibition laws."

"The war on drugs has been a failure by every measure," said Neill Franklin, the executive director of Law Enforcement Against Prohibition. "After more than a trillion dollars spent over the last forty years, we have nothing to show for it except more violence on our streets, the fracturing of community trust in the police and overflowing prison populations. Still, use has not significantly declined. It's unfortunate the DEA heads can't admit this failure. As someone who gave three decades of his life fighting this 'war' on the ground, I can tell you that from that perspective, this policy was dead on arrival."

"It is not surprising that these ex-heads of the marijuana prohibition industry are taking action to maintain the policies that kept them and their colleagues in business for so long," said Mason Tvert, communications director for the Marijuana Policy Project and an official proponent of the Colorado initiative. "Their desire to keep marijuana sales in an underground market favors the drug cartels, whereas the laws approved in Colorado and Washington favor legitimate, tax-paying businesses. Marijuana prohibition has failed, and voters are ready to move on and adopt a more sensible approach. It's time for these former marijuana prohibitionists to move on too."

As for INCB, it essentially plays the role of toothless nag, said Eric Sterling, the executive director of the Criminal Justice Policy Foundation. It is mandated by the United Nations to report on adherence to global anti-drug treaties, but has only the power to hector, not to enforce.

"The INCB has no power other than to issue reports," he said. "It can't issue indictments, it can't call for a resolution in some other body to condemn a nation. It's strictly hortatory, and for many years, it's bordered on the preposterous in the condemnations it's made. The INCB thinks that nations ought to suppress music or motion pictures or books that 'send the wrong message' about drugs. In that sense, it is completely out of step with Western Civilization. They would reject art and music and probably science if it were contrary to their abstinence focus on drug use."

Not only is the INCB relatively powerless, it is largely irrelevant, Sterling said.

"In our American drug policy, they have only negligible influence," he said. "I don't think that in any state capital, the INCB's comments carry any political weight. I don't think in most journals of opinion, their observations are important. Whether their comments have significance in other countries would be harder for me to assess. I tend to believe they are not that important," he said.

"Most people don't even know what it is or what its power is or what it said, including most members of Congress and their staffs," Sterling continued. "The INCB is obscure. Maybe some former DEA administrators might want to refer to them in a press release, but nobody else is going to pay any attention."

The forces of opposition to marijuana legalization are lining up to put pressure on the Obama administration. It shouldn't listen to them, said DPA's Nadelmann.

"President Obama and Attorney General Holder really need to allow Washington and Colorado officials to implement the new laws in ways that protect public safety and health while respecting the will of those states’ voters," he said. "At this point, insisting on blind obeisance to strict interpretation of federal drug laws will only serve the interests of criminals who want to keep this industry underground and law enforcement officials who want to justify their legacy."

And the wait for clarity from Washington continues...

More Overreaching Arguments Against Marijuana Legalization by DEA Chiefs and the UN

Colorado billboard, 2012
The International Narcotics Control Board, a UN agency, and eight former DEA administrators came out swinging this week against marijuana legalization in Colorado and Washington. The INCB says the state laws violate UN treaties. The DEA chiefs want the Obama administration to sue to block the laws.

Both of those positions may be overreaches. It's true that federal marijuana legalization would require revision of the drug treaties, if the US is not to be in violation of them (or for the US to do what Bolivia did by withdrawing and then rejoining "with reservations"). Legalization by Congress even just within states that have enacted it is also a likely treaty issue. But Colorado and Washington aren't parties to the treaties, and federal law remains in force within those states. The states have simply ceased to contribute their own resources to a part of the prohibition program. Under our federal system they very probably have the legal right to do so.

And that is why the DEA chiefs have overreached as well. When one says that federal law is supreme in this area, it means that federal agents can use the powers they have to bring criminal or civil actions against marijuana users or sellers, despite the passage of state laws -- the Raich case decided that for medical marijuana, for reasons that would seem to apply to fully legalized marijuana too. But that doesn't mean the states have to help them. We have a federal system. As I've pointed out previously, no federal prosecutor in 16 years of state medical marijuana laws has ever argued in court that the states can't have those laws on their books. Clearly they've had incentive to do so, if they thought they could win that way.

I don't argue that we know for sure how these points will come out if they are adjudicated -- it is new legal territory. But most legal scholars seem to think a preemption ruling would be a long shot outcome. So that is how it looks to me.

[If you haven't already, please order the two recent reports, from the Cato Institute and the London School of Economics, addressing these two very issues -- available in harcopy on our web site for a small donation.]

Appeals Court Ruling Throws Wrench in Maritime Drug Prosecutions [FEATURE]

special to Drug War Chronicle by Clarence Walker, freelancewriter82@gmail.com

America's war on drugs overseas was dealt a heavy blow in the federal courts late last year. In November, the 11th US Circuit Court of Appeals in Atlanta handed prosecutors a crushing defeat by reversing the multiple drug convictions of four foreign nationals arrested after their fishing vessel with 760 kilos of cocaine was seized off the Panamanian coast three years ago. That cocaine was valued at between $180 million and $200 million.

Coast Guard drug bust, 2004
The defendants were convicted and sent to prison under a never before challenged provision of the federal Maritime Drug Law Enforcement Act. The ruling reversing their convictions has called into question current US war drug tactics on foreign territory and territorial waters.

If upheld, the decision in US v. Bellaizac-Hurtado, could prevent the US from prosecuting suspected smugglers caught within the 12-mile territorial waters of South and Central America countries, and it may hinder US authorities from entering the 12-mile limit themselves while carrying out anti-narcotics operations. That would wreak havoc with US drug enforcement offensives such as Operation Martillo (Hammer), which has been aimed squarely at Central America and has so far seized over $2 billion worth of drugs from sea-going vessels.

Federal prosecutors haven't said whether they will appeal, but it would be a surprise if they didn't.

As the justices at the 11th Circuit noted, the Bellaizac-Hurtado case is the first taken up during modern times to determine whether the "Offenses clause" of the US Constitution can legally allow US prosecution of drug trafficking crimes in another country. The Offenses clause gives Congress the right to "define and punish… Offenses against Law of Nations."

The court found that the use of the clause to justify the prosecution of Bellaizac-Hurado under the Maritime Drug Law Enforcement Act is illegal because drug trafficking was not a crime under the Law of Nations when the Constitution was written more than two centuries ago, nor is it a crime under "customary international law" now. The pursuit of felony crimes overseas is limited by customary international law, and the international community has not treated drug trafficking under these premises as a crime, the court held.

"Drug trafficking was not a violation of customary international law during the 'Founding of the US law' and drug trafficking is not a violation of customary international law today," the opinion stated. "Because drug trafficking is not a violation of customary international law, we hold that Congress exceeded its power, under the Offences Clause, when it proscribed the defendants' conduct in the territorial waters of Panama. And the United States has not offered us any alternative ground upon which the Act could be sustained as constitutional. As applied to these defendants, the Act is unconstitutional, and we must vacate their convictions."

While the ruling found the act could not be used to prosecute suspected drug smugglers arrested within a country's 12-mile territorial waters, it does not impact cases against smugglers using "stateless" submarines, nor impede the ability of US authorities to prosecute felonies committed on "the high seas."

The potentially precedent-setting case began in 2010 when US Coast Guard patrols in Panamanian waters spotted a wooden fishing vessel operating without lights or a flag. Suspicious, the Coast Guard alerted the Panamanian Navy and the chase was on. The Navy officers chased the vessel until the suspects abandoned the ship and fled on land deep into Panama's jungle. Following a thorough search of the vessel the Coast Guard discovered "760 kilos of cocaine." The feds had scored a mother lode. Meanwhile the four occupants of the vessel were arrested the next day in the jungle by Panamanian National Frontier Service.

Through a diplomatic agreement, Panama handed the captured men over to the US for prosecution.They were indicted in Florida's Southern District in Miami for conspiracy and possession with intent to distribute five kilograms or more of cocaine aboard a vessel subject to US jurisdiction under the Maritime Drug Law Enforcement Act.

They were convicted and sentenced to federal prison. Their attorneys, led by Miami defense attorney Tracey Dreispul, appealed. The Maritime Drug Law Enforcement Act was unconstitutional because it exceeded Congress' constitutional powers under the Offenses Clause, they argued.

The Justice Department responded that "drug trafficking is an offense against 'Law of Nations' as applied to the defendants' conduct -- -subject to Universal Jurisdiction because when Congress enacted the Maritime Drug Law Enforcement Act, it stated that drug trafficking is 'universally condemned' and a threat to the security and societal well-being of the United States." Prosecutors also argued that "the US federal district court had lawful jurisdiction over the cocaine because the defendants had been operating a vessel without a flag or national identification, and that the Panamanian government consented to have the men prosecuted in the United States."

But the appeals court in Atlanta wasn't buying it. "Offenses against Laws of Nations can only be interpreted in accordance with principles of customary international law because international law proscribes which conduct may be punished as an Offense against the Laws of Nations," the court held.

In other words, Congress doesn't get to define what constitutes customary international law.

"Where does the government get off on by prosecuting people they don't have the power to prosecute?" asked attorney Stephen Leckar, counsel for the defense in the landmark US v. Antoine Jones GPS drug trafficking case, in an interview with the Chronicle. "Where is the evidence that the drugs were headed for the US market to be distributed?"

"This basically was a Panamanian internal matter and their government is saying 'United States, you clean this up for us,'" Miami lawyer Phillip Horowitz, who represented one of the defendants, told the Miami Herald.

The ruling could have a cascading effect, impacting some of the thousands of drug smuggling cases stemming from offshore arrest. Legal experts predict that if the ruling withstands appeal, other convicted drug smugglers may go free if they, too, were arrested in foreign territorial waters by international police, then turned over to US for prosecution under "Offences against Laws of Nations."

Those defendants need to act, though, said Florida defense attorney David Silverstein. "Any defendants convicted under the same set of facts in Bellaizac-Hurtado must file a writ of habeas corpus within two years after the opinion was issued," he told the Chronicle.

With their convictions now voided, it remains to be seen if Bellaizac-Hurtado and his codefendants will now be prosecuted by Panamanian authorities. If so, let's hope they get credit for time served. Luis Carlos Hurtado did 25 months, Pedro Angulo-Rodallega and Albeiro Gonzales did 36 months, and Yimmie Bellaizac-Hurtado is still doing his 90-month sentence pending resolution of the appeals. The others have been deported.

Atlanta, GA
United States

Medical Marijuana Update

From the village board to the halls of Congress, medical marijuana is popping up all over. And there's action at various state houses, too. Let's get to it:

National

Last weekend, Americans for Safe Access hosted the National Medical Cannabis Unity Conference in Washington, DC. The conference featured numerous panelists, as well as lobbying on Capitol Hill.

On Monday, Rep. Earl Blumenauer (D-OR) introduced the States' Medical Marijuana Patients Protection Act (House Resolution 689) at a press conference surrounded by attendees at the National Medical Cannabis Unity Conference. The bill would get the federal government out of states where medical marijuana is legal.

Arizona

Last Thursday, an unapproved dispensary was shut down in Kingman and its proprietors arrested on a variety of marijuana-related and weapons charges. Police seized several pounds of marijuana, $7,000 in cash, and a shotgun.

California

Earlier this month, Shasta County moved a lawsuit filed against it by a medical marijuana collective from state to federal court, and the attorney representing county supervisors has already filed a motion there to dismiss it. The Medicine Man Collective Spiritual Center Corporation sued in state Superior Court in January, naming the supervisors, the county sheriff, and three deputies as defendants. The suit charges that the county conspired to deprive the collective of its contractual, constitutional and state rights by enacting a ban on dispensaries. The collective closed its Main Street doors in May 2011 after being evicted following implementation of the ban in 2010 and its finalization the following year.

Last Thursday, the LA city council voted to approve a third dispensary measure for the May ballot. This third measure is the council's own and would allow about 100 dispensaries to stay open, restrict them from locating near schools and churches, and increase taxes on them. One of the other measures would allow a similar number of dispensaries to stay open, while the other would allow most of the hundreds of currently existing dispensaries to stay open. The initiatives come after the council tried to impose a total ban last year.

On Tuesday, Butte County supervisors adopted a cultivation ordinance. The measure prohibits outdoor marijuana gardens on lots smaller than 0.5 acre. It allows up to 12 plants (six mature and six immature) on parcels larger than 0.5 acre but smaller than 1.5 acre. On parcels smaller than 3 acres, 36 plants (18 mature and 18 immature) are allowed. The total allowable number of plants tops out at 99 on property larger than 40 acres. The gardens have set-back requirements that increase as the lots grow, and the plants have to be screened from view with fencing. Grows are prohibited within 1,000 feet of schools and parks. The growers have to be able to prove they have been county residents for a year, and there has to be written proof the landowner is aware of the garden and approves of its existence. The ordinance allows  indoor gardens in free-standing buildings of 120 square feet on lots anywhere in county jurisdiction.

Florida

On Tuesday, a statewide poll had support for medical marijuana at 69%. The poll showed strong support among Democrats and independents and even among Republicans, 56% of whom said they supported marijuana. The poll comes as its sponsor, People United for Medical Marijuana, pushes for medical marijuana to come to the Sunshine State.

On Wednesday, a medical marijuana bill was filed. The bill is Senate Bill 1250.

Iowa

On Sunday, a statewide poll found that 58% support legalizing medical marijuana. That's down six points from a similar poll in 2010. The poll comes as the Iowa legislature considers medical marijuana bills.

Massachusetts

On Tuesday, the Westborough Board of Health supported zoning for dispensaries. The board did not reach agreement on whether Westborough should ban dispensaries or whether to zone or ban home grows for medical use. The town planning board has already proposed a zoning bylaw that would ban both dispensaries and home grows. It goes before voters at the annual town meeting on March 16.

Montana

Last Thursday, two more medical marijuana providers were sentenced to federal prison terms. Ross Pattison and Brandon Strecker were partners in Eastern Montana Cannabis. Pattison got 20 months and Strecker got a year and a day. They are only the latest Montana medical marijuana providers to be sent to federal prison after a spring 2011 crackdown by the DEA and the Justice Department.

Nevada

Last Friday, legislators held a hearing on problems with access to medical marijuana. During the Senate Judiciary Committee hearing, members acknowledged that it is almost impossible for the state's 3,600 card holders to acquire their medicine. Sen. Tick Segerblom (D-Las Vegas) said after the hearing that he soon will introduce a bill to set up a regulated system where marijuana is grown at farms and then distributed and taxed through licensed dispensaries.

New Hampshire

Last Thursday, a House committee held a hearing on a pending medical marijuana bill. The bill, House Bill 573, would allow patients to grow up to four plants or obtain their medicine through one of five state-licensed dispensaries. Similar bills have twice passed the legislature since 2007, only to be vetoed by then-Gov. John Lynch (D). New Gov. Maggie Hassan (D) supported the bills as a legislator, but has expressed concerns that the system be tightly regulated.

Oklahoma

On Monday, a medical marijuana bill died in the legislature. The bill, Senate Bill 710, would have allowed patients to possess up to eight ounces and grow up to 12 plants. It would also have allowed state-sanctioned collectives. It was killed in the Senate Health and Human Services Committee after members heard testimony. The bill was defeated 6-2 in a party line vote.

Washington

On Monday, the Spokane city council approved a six-month moratorium on new dispensaries. The council feared a proliferation of marijuana businesses before the state finishes writing its rules for legal non-medical marijuana commerce. Spokane currently has about a dozen dispensaries.

Bipartisan Hemp, Medical Marijuana Bills Introduced in Congress [FEATURE]

It's a marijuana policy trifecta on Capitol Hill now: recreational marijuana, medical marijuana, and hemp. Earlier this month, reformist House members filed bills to end federal pot prohibition and tax the trade and last week to legalize hemp. Now, some of those same legislators -- joined by more -- have filed bills that would protect medical marijuana patients and providers and some senators have filed their companion bill to legalize industrial hemp.

Kentucky Republicans McConnell and Paul are supporting hemp legislation in the Senate
Phase II took place Thursday, when Rep. Earl Blumenauer (D-OR), sponsor of the above-mentioned marijuana tax bill, rolled out House Resolution 689, the States' Medical Marijuana Protection Act; Rep. Sam Farr (D-CA) introduced House Resolution 710, the Truth in Trials Act; and Sen. Ron Wyden (D-OR) and three co-sponsors filed the Industrial Hemp Farming Act of 2013, the companion to House Resolution 525.

Blumenauer's bill would grant federal recognition to the use of medical marijuana and remove it from Schedule I of the Controlled Substances Act. Regulating medical marijuana would be left to the states, and people complying with state medical marijuana laws would be exempt from federal arrest and prosecution.

It was introduced with bipartisan co-sponsorship, including Reps. Steve Cohen (D-TN), Sam Farr (D-CA), Raul Grijalva (D-AZ), Alcee Hastings (D-FL), Michael Honda (D-CA), Jared Huffman (D-CA) ), Barbara Lee (D-CA), James Moran (D-VA), Jerrold Nadler (D-NY), Jared Polis (D-CO), and Dana Rohrabacher (R-CA).

"The States' Medical Marijuana Patient Protection Act will allow medical marijuana patients and businesses -- who are complying with state law -- the ability to access and distribute marijuana free from federal interference," Blumenauer said. "Nineteen jurisdictions have passed laws recognizing the importance of providing access to medical marijuana for the hundreds of thousands of patients who rely on it. It is time for the federal government to respect these decisions, and stop inhibiting safe access."

"There is a plethora of scientific evidence establishing marijuana’s medical safety and efficacy and public polling for marijuana law reform is skyrocketing," said Jasmine Tyler, deputy director of national affairs for the Drug Policy Alliance. "However, when it comes to marijuana and the federal government, old fashioned politics routinely trumps modern science. The States' Medical Marijuana Patient Protection Act offers us hope we will see significant change with its passage. Congress should move swiftly to acknowledge what patients, doctors, researchers and scientists have been telling us for years: marijuana has therapeutic and medicinal benefits," said Tyler.

Farr's Truth in Trials Act is an attempt to restore fairness in federal medical marijuana prosecutions. Because the federal government refuses to recognize marijuana as anything other than a proscribed controlled substance, medical marijuana defendants and their attorneys are barred from even mentioning it or their state laws allowing its use in federal court. That has repeatedly resulted in state law-abiding medical marijuana growers and providers being convicted as drug dealers in federal courts, and sentenced accordingly.

Similar legislation has been introduced in previous years, but made little progress. Now, however, as the Obama administration keeps up the pressure on medical marijuana providers and in the wake of November's election results, supporters hope the bill can gain some traction.

This year's bill is cosponsored by Reps. Earl Blumenauer (D-OR), Steve Cohen (D-TN), Raul Grijalva (D-AZ), Barbara Lee (D-CA), James Moran (D-VA), Chellie Pingree (D-ME), Jared Polis (D-Co), Dana Rohrabacher (R-CA), and Henry Waxman (D-CA).

"The federal government for too long has denied due process to defendants who can demonstrate that they were using medical marijuana legally under local or state law," Farr said. "This bill would ensure that all the evidence is heard in a case and not just the evidence that favors conviction."

"Congress has the opportunity to establish a sensible public health policy on medical marijuana, and do what the Obama Administration has been afraid or unwilling to do," said Steph Sherer, executive director of Americans for Safe Access (ASA), which has been working with members of Congress to advance this legislation. "Patient advocates intend to push Congress to take heed of the abundant scientific evidence showing marijuana's medical value, and act in accordance with the overwhelming popular support this issue receives."

ASA is holding its first ever National Medical Cannabis Unity Conference this month in Washington, in part to do a big lobbying push for the bills. Attendees will convene in Washington on Friday, with the four-day conference culminating with a press conference and lobby day on Capitol Hill on Monday.

And then there was hemp. With Sen. Wyden's introduction of a Senate bill, there are now hemp bills in both houses. In addition to Wyden and Democratic and fellow Oregonian Sen. Jeff Merkley (D), the Senate hemp bill has the support of Sens. Rand Paul (R-KY) and Senate party leader Mitch McConnell (R-KY), both of whom have also endorsed hemp legislation back home in Kentucky.

"I am proud to introduce legislation with my friend Rand Paul and Senate colleagues, that will allow Kentucky farmers to harness the economic potential that industrial hemp can provide," McConnell said. "During these tough economic times, this legislation has the potential to create jobs and provide a boost to Kentucky's economy and to our farmers and their families."

"The Industrial Hemp Farming Act paves the way to creating jobs across the country -- from Kentucky to Oregon and everywhere else," Paul said. "Allowing American farmers to cultivate industrial hemp and benefit from its many uses will boost our states' economies and bring much-needed jobs in the agriculture community."

The House version of the bill was introduced earlier by Rep. Thomas Massie (R-KY) and has 28 cosponsors: Reps. Justin Amash (R-MI), Dan Benishek (R-MI), Earl Blumenauer (D-OR), Suzanne Bonamici (D-OR), John Campbell (R-CA), Lacy Clay (D-MO), Steve Cohen (D-TN), Peter DeFazio (D-OR), Keith Ellison (D-MN), Sam Farr (D-CA), Raul Grijalva (D-AZ), Richard Hanna (D-NY), Barbara Lee (D-CA), Tom McClintock (R-CA), Jim McDermott (D-WA), George Miller (D-CA), James Moran (D-VA), Jerrold Nadler (D-NY), Eleanor Norton (D-DC), Collin Peterson (D-MN), Chellie Pingree (D-ME), Mark Pocan (D-WI), Jared Polis (D-CO), Dana Rohrabacher (R-CA), Jan Schakowsky (D-IL), Kurt Schrader (D-OR), John Yarmuth (D-KY), and Ted Yoho (R-FL).

The hemp bills would remove federal restrictions on the domestic cultivation of industrial hemp. Specifically, the bill would remove hemp from the Schedule I controlled substance list under the Controlled Substances Act of 1970, and would define it as a non-drug so long as it contained less than 0.3 percent tetrahydrocannabinol (THC).

Eight states, including Oregon, have already passed bills providing for legal hemp production, but action in those states is on hold because the DEA refuses to recognize any difference between hemp and marijuana. That means US hemp product manufacturers must import hemp from countries that do recognize the difference between hemp and marijuana.

"Unfortunately, there are some dumb regulations that are hurting economic growth and job creation, and the ban on growing industrial hemp is certainly among them," Wyden said. "The opportunities for American farmers and businesses are obvious here. It's time to boost revenues for farmers and reduce the costs for the businesses around the country that use hemp."

Congress now has a full-blown marijuana agenda on its plate, from pot legalization to industrial hemp to medical marijuana, if it chooses to address it. And, given the overlapping cosponsorships on the various bills, it now appears to have developed a cannabis caucus. We've already come a long way from the days when it was all up to Barney Frank and Ron Paul, and they've just been gone a few weeks.

Washington, DC
United States

Legalization Foes Come Out Swinging Against Marijuana [FEATURE]

Two states have already legalized marijuana, bills to do the same have been or will be filed in a half-dozen more this year, a federal bill to repeal pot prohibition has also been introduced, legalization initiatives aimed at 2014 or 2016 are already being plotted, and public opinion polls are showing support for marijuana legalization edging into majority territory. The opposition is started to get worried.

Anti-prohibitionists aren't the only ones targeting Congress.
And it is moving to blunt the legalization trend. While official Washington has so far remained largely silent in the face of the fact of legalization in two states and the threat of it in more in the near future, special interests threatened by the end of marijuana prohibition and self-appointed anti-pot crusaders are starting to stage a pushback. While it is tempting to dismiss the crusaders as being on the wrong side of history, reform advocates are wary of their advocacy and say the good guys need to step up their game.

Project SAM (Smart About Marijuana), the recently formed brainchild of former Congressman-with-addiction-issues Patrick Kennedy (D-RI) and former Office of National Drug Control Policy staffer Kevin Sabet, last week authored a letter to US Attorney General Eric Holder calling on him to stand firm against marijuana legalization.

Its co-signers include a veritable cavalcade of beneficiaries of government drug spending, among them the federally-funded Community Anti-Drug Coalitions of America, the National Narcotics Officers Association Coalition, and the National Association of Drug Court Professionals (NADCP). Other signers are a Colorado pediatric physicians' group and Smart Colorado, "a broad-based alliance of concerned public health officials," which is funded almost entirely by Mel and Betty Sembler, long-time drug warriors notorious for having operated abusive treatment programs for teens in the 1990s.

"We are writing to you to enforce the Controlled Substances Act (CSA) in Colorado and Washington with respect to recent ballot measures legalizing marijuana," wrote Kennedy and the gang. "These state laws would severely threaten public health and safety goals, expressly contradict the President’s National Drug Control Strategy, make it impossible to comply with federal regulations, and present an obstacle to the achievement of Congress' discernible objectives to prohibit the use, sale, manufacture, and distribution of marijuana. We urge you to restate marijuana is illegal."

The marijuana legalization laws in Washington and Colorado "violate both the intent of Congress in enacting the CSA and the letter of the law," the letter continued. "The Department of Justice and Congress have determined through the CSA that marijuana is a Schedule I drug and as such growing, distributing, and possessing marijuana in any capacity, save a federal research program, is in 'violation of federal law regardless of state laws permitting such activities.'"

Project SAM advocates prevention and drug treatment for marijuana users and wants to avoid stigmatizing them, but still wants marijuana to be illegal.

"There is an arrest and prosecution industry in this country that depends on marijuana remaining illegal to maintain their budgets and stay in business," retorted Mason Tvert, one of the key organizers of the Colorado initiative and now a spokesman for the Marijuana Policy Project. "As Project SAM has said, we need to be focusing our attention on providing treatment to those who need it, but unfortunately their stance on marijuana would waste treatment resources on people who don’t. These groups talk about teens using marijuana, and if their true goal was preventing teen marijuana use, we would gladly join them, but their real goal is to keep marijuana illegal, and that doesn't benefit teens or anyone else… but themselves."

For one of the Project SAM signatories, signing on to somebody else's letter wasn't enough. The NADCP Monday released its own position statement against legalizing marijuana, saying "every dangerous and addictive drug was once believed to be safe and medicinal."

NADCP "unequivocally stands against the legalization of marijuana and the use of smoked marijuana as medicine," the group said. Society need not fall for the "false choice" of legalization or incarceration when it can find a third way through the "curative effects of drug courts and dozens of other treatment programs."

"Drug court is the equivalent of purgatory in the Catholic theology," commented Allen St. Pierre, executive director of the National Organization for the Reform of Marijuana Laws. "If you comport with their demands and accept your moral turpitude, they may let you ascend. But if you fail the drug test or don't show proper deference to the system, you will not only be stuck in purgatory, but may pushed down into the bowels of hell," the veteran activist said.

"We get calls all the time from people facing this Hobbesian choice of drug courts or traditional courts, and we have to warn them that, unlike the early 1990s, when they looked like a good alternative to incarceration, we have seen so many cases where individuals face far worse penalties, fines, and incarceration in drug court than if they took the worst plea bargain in regular court. Drug court pleaders belong in the category of special interests who clearly benefit -- if not exist wholly -- because of this government prohibition."

Reformers should not take this new opposition lightly, some reformers say.

"While these groups are completely dependent on federal government anti-drug money and can be discounted as fighting to protect their own rice bowls, it would be a naïve and arrogant mistake to ignore them," said Eric Sterling, executive director of the Criminal Justice Policy Foundation. "Kevin Sabet is an energetic guy, and these groups have lots of taxpayer money to spend on this. They will mobilize in other states, and they have the ability to get the ear of the attorney general and others."

Similarly, said Sterling, "to a lay person, the NADCP statement is an impressive statement," even though policy and other experts may see their claims as overstated.

"People in reform should be concerned about a reaction," he said. "It is certain that these documents represent products being developed by a concerted movement to turn back the tide. The opposition is first out of the box on this," Sterling warned as he wondered aloud what the reform movement is doing to counter the counter-revolution.

"I was told in November that folks at Justice were completely blindsided by the victories in Colorado and Washington," he said. "What written correspondence to Holder can we point to about what they should do? I know there have been some informal conversations between state officials and the attorney general, but there is nothing in writing that both lays out a plea and a case for accommodating state laws."

That reflects a broader problem of lack of aggressiveness within the reform movement, he said.

"On one level, the reform movement is not being proactive," Sterling argued. "It's one thing to get an initiative passed, and we've demonstrated a high degree of competence at that, but we haven't seen that same sort of competence when it comes to Washington. It's a much more complex and tricky problem to mobilize a majority of the House or Senate, and there has not been a well-organized effort on a sustained basis to get Congress to weigh in. It's amazing to me that so far after 1996, no senator has ever introduced a bill to allow their state to have a medical marijuana program free from federal interference. There are now 36 senators from 18 medical marijuana states, and not one of them has ever introduced a bill. That's an amazing failure to organize by our movement."

The movement -- especially that part of it with deep pockets -- needs to step up, Sterling said.

"I'm not aware that any of our movement organizations have a strategy for getting the American Bar Association or other high-profile groups to take a position on marijuana enforcement after the passage of the initiatives," he said. "Those kinds of campaigns need to be thought about and have people assigned to do them. I haven't done that either, but I'm not a leader of any of the 'angel organizations' that do this work."

While the reform movement builds itself, it can still attack the foe, St. Pierre said.

The opposition is actively pushing back now. Reformers are working quietly with state officials on implementation of regulation, but they can't forget that Washington is where some crucial decisions get made. Project SAM and its allies certainly haven't.

Medical Marijuana Update

The California Supreme Court heard oral arguments in a key case on whether localities can ban dispensaries, and medical marijuana bills died in two Midwest states, and there's more news, too. Let's get to it:

California

Last Thursday, the Obama administration sought to dismiss a lawsuit by the city of Oakland defending its ability to issue permits for dispensaries. Oakland had sued the feds after US prosecutors moved against the Harborside Health Center, seeking to shut it down. The Justice Department argued that the city was using the wrong legal remedy, but Oakland argued that shutting down Harborside would send tens of thousands of patients into the streets seeking medicine, posing a threat to public safety in a city with crime problems. No ruling was made.

Also last Thursday, the LAPD raided a massive grow up that supplied dispensaries. LAPD officers and US Homeland Security gang agents found 1,500 pounds of marijuana and several firearms. Police said the warehouse grow did about $7.6 million in business every 60 days, and supplied numerous dispensaries in Southern California. Authorities also allege it was shipping marijuana to the Midwest and East Coast. Four people were arrested; their names have not been released.

On Monday, San Diego District Attorney Bonnie Dumanis dropped the charges against two medical marijuana patients. The move came in the cases of Clint Guidry and Cameron Mitchell, and represented a setback for the staunchly anti-medical marijuana Dumanis.

On Tuesday, LA City Attorney Carmen Trutanich said dispensaries should be allowed to operate in the city. Up for reelection, the formerly anti-dispensary Trutanich said he was endorsing a city council initiative that would allow the 100 to 180 retailers that existed before a fall 2007 city moratorium on dispensaries to essentially carry on so long as they follow certain rules. A second initiative also set for the ballot would allow virtually all of the city's hundreds--possibly up to a thousand--dispensaries to stay open.

Also on Tuesday, the state Supreme Court heard oral arguments in a key dispensary ban case. The issue is whether the city of Riverside's ban on dispensaries violates the state's medical marijuana laws. Questioning by the justices suggested that they were prepared to agree with the city that the state constitution gives cities wide policing power over land use and suggested that the state's medical marijuana laws have not undercut that authority.

On Wednesday, DEA agents and San Bernardino police raided a chain of dispensaries and a private residence. The raiders hit Kush Concepts at three locations, where they marched patients out of the dispensaries. City officials said there are 41 dispensaries in San Bernardino.

Also on Wednesday, an appeals court upheld Tehama County's cultivation ordinance. A group of medical marijuana patients sued over the ordinance in 2010, arguing it was unconstitutional and conflicted with the Compassionate Use Act. The county prevailed in Superior Court, and that decision was appealed. Now that appeal has been lost.

Colorado

Last Tuesday, the first applications for Fort Collins dispensary licenses were submitted. The city had had 21 dispensaries that were forced to close when voters chose to impose a ban in 2011. The ban was overturned by voters in November, and now the dispensaries are coming back.

Iowa

Last Thursday, legislators killed a medical marijuana bill. House Public Safety Committee Chair Clel Baudler (R-Greenfield) call it one of the "stupidest" bills he had ever seen. He was joined by the other Republican on the three-member panel in voting to kill it.

Massachusetts

On Sunday, state officials said they may not make the deadline to come up with medical marijuana regulations. They are required to have them in place by May 1, but health officials said the complexity of the issues was such that they were unlikely to be able to comply. Medical marijuana advocates responded that any delay is unjustified and would cause patients to suffer.

Michigan

On Tuesday, a report said the state had collected $10 million in revenues from medical marijuana program applicants. The report covered the period through the end of the state's budget year on September 30. It says the revenue intake was nearly double that needed to run the program.

Montana

Last Friday, Chris Williams was sentenced to a mandatory minimum five years in prison for his role in Montana Cannabis, the state's largest dispensary during its short-lived medical marijuana boom. He had been facing more than 90 years in federal prison after refusing plea agreements and then being convicted of marijuana cultivation and firearms offenses in federal court (they had a shotgun at their grow op), but in the face of a public outcry, prosecutors sought and got an unusual post-conviction plea bargain limiting his prison exposure.

South Dakota

On Tuesday, a medical marijuana bill was killed in the legislature. It went down on a 7-6 vote in the House Health and Human Services Committee. Medical marijuana bills have been repeatedly introduced since 2001, only to die. South Dakota voters have also twice rejected medical marijuana initiatives.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum), Synthetic Drugs (Mephedrone, Synthetic Cannabinoids)YouthGrade School, Post-Secondary School, Raves, Secondary School